US Patent 10085992 Transient protection of normal cells during chemotherapy
Patent 10085992 was granted and assigned to G1 Therapeutics on October, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10085992 Transient protection of normal cells during chemotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.